Bodhi Tree Biotechnology Inc.
Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $17.0K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $164.6K |
| Operating Income | $-147.6K |
| Operating Margin | -868.3% |
| Interest Expense | — |
| Pretax Income | $-147.6K |
| Income Tax Expense | $2.1K |
| Net Income | $-149.7K |
| Net Margin | -880.4% |
| EPS (Basic) | $-0.01 |
| EPS (Diluted) | $-0.01 |
| Shares Outstanding (Basic) | 25.4M |
| Shares Outstanding (Diluted) | 25.4M |
| Dividends Per Share | — |